4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-001898
CFO & Chief Business Officer sold 6,888 shares at $1.82 ($12,513)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2026-01-08 | Sale | −6,888 | $1.82 | $12,513 | 209,951 | D |
| Open-market sales · 6,888 sh · avg $1.82 · $12,513 | |||||||
Loading xslF345X05/wk-form4_1768261959.xml…